PF-Atlas › Исследования › Korean Language
Исследования: Korean Language (43)
43 публикаций в теме «Korean Language», проиндексированных PF-Atlas из PubMed и мировых журналов.
- Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis : a Phase 2b Randomized Placebo-Controlled Trial. · American journal of respiratory and critical care medicine · 2026
- Clearing the Pulmonary Traffic Jam With Dual-Enzyme Inhalable Nanoparticles Restore Airflow and Reverse Fibrotic Remodeling. · Advanced healthcare materials · 2026
- The Effect of Food on the Pharmacokinetics and Gastrointestinal Tolerability of Bersiporocin, a Novel Oral Prolyl-tRNA-Synthetase Inhibitor. · Drug design, development and therapy · 2026
- Overlapping mechanisms and novel biomarkers define asthma and chronic obstructive pulmonary disease as a spectrum of airway diseases. · Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
- ABRL8301, a Novel 2-Methoxyestradiol Derivative, Mitigates Progressive Pulmonary Fibrosis by Downregulating 11β-Hydroxysteroid Dehydrogenase 1. · European journal of pharmacology · 2026
- Exosomes as Disease-Informed Nanoplatforms for Pulmonary Fibrosis: From Pathogenic Signaling to Precision Diagnosis and Therapy. · Pharmaceutics · 2026
- Crisaborole 2% for Pediatric Periorificial Dermatitis: A Randomized, Double-Blind, Vehicle-Controlled Pilot Study. · Annals of dermatology · 2026
- Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative. · Pharmaceutics · 2026
- AI-enabled label free monitoring of TGFβ1-induced remodeling in iPSC-derived alveolar organoids. · Materials today. Bio · 2026
- Single-cell Sequencing Unveils A Profibrotic Macrophage and Infiltrating Monocyte Niche in the Bronchoalveolar Lavage of Patients with Chronic Obstructive Pulmonary Disease. · American journal of respiratory and critical care medicine · 2026
- Telomere biology disorders associated with childhood interstitial lung disease. · Clinical and experimental pediatrics · 2026
- Nanochemical modulation of ECM-driven pseudo-resistance: convergent microenvironmental pathways in COVID-19 and cancer. · Chemical communications (Cambridge, England) · 2026
- Cellular Senescence: Emerging Therapeutic Target for Idiopathic Pulmonary Fibrosis Pathogenic Mechanisms and Therapeutic Strategies. · Biomolecules & therapeutics · 2026
- EGFR and Its Ligands in Idiopathic Pulmonary Fibrosis: Predicting Clinical Outcomes and Molecular Endotyping Through In-Depth Analysis. · Journal of Korean medical science · 2026
- Circulating Adipokines as Diagnostic and Prognostic Markers in Idiopathic Pulmonary Fibrosis. · Lung · 2026
- Evidence-Based Exploration of Exposure-Matched Candidate Pirfenidone Dose for East Asian Populations based on Population Pharmacokinetic Modeling and Simulation Approach. · Clinical therapeutics · 2026
- Multisystem IgG4-Related Disease Mimicking Malignancy With Cavitary Pulmonary Nodules, Pleural Thickening and Hepatic Mass-Like Lesions: A Case Report. · Respirology case reports · 2026
- Clinical characteristics and factors associated with progressive pulmonary fibrosis in patients with systemic sclerosis-associated interstitial lung disease. · Clinical rheumatology · 2026
- Biodistribution and toxicity of inhaled nickel oxide nanoparticles: Potential application to realistic exposure. · Toxicology and applied pharmacology · 2026
- Tryptophan metabolism as a key integrator within the gut-lung-brain axis: Mechanistic insights and nutritional therapeutic strategies for inflammatory and neuropsychiatric disorders. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
- Effects of combination metformin and nintedanib therapy in a mouse model of irradiation-induced pulmonary fibrosis. · Journal of radiation research · 2026
- Evolving landscape of imaging-based evaluation in systemic autoimmune rheumatic disease-associated interstitial lung disease: from visual assessment to quantitative artificial intelligence-assisted evaluation. · Journal of rheumatic diseases · 2026
- Single-Cell Analysis Identifies Factors Associated with Rheumatoid Arthritis-Related Interstitial Lung Disease in Comparison with Idiopathic Pulmonary Fibrosis. · Tuberculosis and respiratory diseases · 2026
- Within-Person Sweat Chloride Variability in People with Cystic Fibrosis Measured via Wearable Microfluidic Sticker. · Annals of the American Thoracic Society · 2026
- Multidimensional assessment of structural post-tuberculosis lung sequelae and respiratory health status in adults from northern Peru. · Frontiers in medicine · 2026
- Collagenous endobronchial obliteration after chemoradiation followed by consolidation osimertinib: a case report. · Frontiers in oncology · 2026
- Korean Clinical Practice Guidelines for Interstitial Lung Disease: Part 2. Idiopathic Pulmonary Fibrosis. · Tuberculosis and respiratory diseases · 2026
- Less is more? Evaluating the role of radioiodine therapy in pediatric differentiated thyroid cancer management. · Annals of pediatric endocrinology & metabolism · 2026
- Clinical impact of hospitalization in patients with idiopathic pulmonary fibrosis: A retrospective cohort study. · Therapeutic advances in respiratory disease · 2026
- Alveolar epithelial depletion of βPAK-interacting exchange factor drives spontaneous pulmonary fibrosis by impairing stemness. · Signal transduction and targeted therapy · 2026
- AdipoRon attenuates lipopolysaccharide-induced acute lung injury with reduced early fibroproliferative remodeling. · International immunopharmacology · 2026
- The Efficacy of Antifibrotics in Combined Pulmonary Fibrosis and Emphysema: A Nationwide Multicentre Retrospective Cohort Study. · Archivos de bronconeumologia · 2026
- Sex-specific COX-2/CREB/ER signaling underlies male susceptibility to pulmonary fibrosis in rheumatoid arthritis-associated interstitial lung disease. · Frontiers in immunology · 2026
- Prevalence and Prognostic Impact of Progressive Pulmonary Fibrosis. · Tuberculosis and respiratory diseases · 2026
- Circadian clock regulation in lung health and disease: molecular mechanisms and therapeutic opportunities. · EXCLI journal · 2026
- Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study. · The Lancet. Respiratory medicine · 2026
- Early fibrotic niches establish tumour-permissive microenvironments. · Nature · 2026
- The antifibrotic effects of a click chemistry-based albumin nanocomplex in an idiopathic pulmonary fibrosis model. · Journal of nanobiotechnology · 2026
- AI-driven discovery of bronopol for the treatment of pulmonary fibrosis via inhibition of fibroblast activation. · Life sciences · 2026
- Targeting the senescence‒autophagy axis via p16 inhibition alleviates pulmonary fibrosis. · Signal transduction and targeted therapy · 2026
- Prospective study of proton beam therapy for non-small cell lung cancer patients with idiopathic pulmonary fibrosis. · Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026
- Pulmonary arterial hypertension from a translational perspective: Bridging pathophysiology and treatment. · Chinese medical journal · 2026
- Nationwide Incidence and Prevalence of Idiopathic Pulmonary Fibrosis in South Korea. · Tuberculosis and respiratory diseases · 2026
Медицинская оговорка. Списки исследований приведены только для информации и не являются медицинской рекомендацией.